Research Triangle Park - Page 11 - Research Triangle Regional Partnership

Durham’s BioCryst lands $44M contract to test anti-viral drug against COVID-19 virus

August 31, 2020

RESEARCH TRIANGLE PARK — BioCryst Pharmaceuticals has landed a $44 million contract to see if its investigational anti-viral drug, galidesivir,…

August 28, 2020

RESEARCH TRIANGLE PARK – T3D Therapeutics, a life science startup seeking to develop a treatment for Alzheimer’s disease, has another…

August 26, 2020

RESEARCH TRIANGLE PARK — RTI International is teaming up with a local biopharma startup to develop a treatment for a…

August 25, 2020

A huge portion of a campus in Research Triangle Park has been sold in a deal that tops $590 million.…

August 21, 2020

RESEARCH TRIANGLE PARK – IMMvention Therapeutix almost hit The Big Pitch out of the park. Almost. The 4-year-old Durham company,…

August 19, 2020

RESEARCH TRIANGLE PARK – G1 Therapeutics, a clinical-stage oncology company based in Research Triangle Park, has reached an important regulatory…

August 17, 2020

A little over a month since opening its second building on South Main Street in Warrenton, Frontier Warren began its…

August 14, 2020

RESEARCH TRIANGLE PARK – UPL, a multinational agriculture company based in India, has opened a global research-and-development hub in Research…

August 12, 2020

RESEARCH TRIANGLE PARK – A young Boston-area gene therapy company, Beam Therapeutics, has joined a cluster of gene and cell…